Methods of evaluating phosphatase inhibitors
    1.
    发明授权
    Methods of evaluating phosphatase inhibitors 失效
    评估磷酸酶抑制剂的方法

    公开(公告)号:US07402406B2

    公开(公告)日:2008-07-22

    申请号:US10493057

    申请日:2002-10-31

    IPC分类号: C12Q1/42 C12N9/14 C07H21/04

    摘要: The present invention identified OVARC1000473 (SEQ ID NO: 1) and NT2RM1000377 (SEQ ID NO: 3) as clones showing suppression of CREB activation by forskolin, and provides evaluation methods using these genes, and/or proteins encoded by these genes. Furthermore, these proteins were found to enhance cell damage. Compounds that can be screened based on the evaluation methods of this invention are useful as agents for inhibiting the CREB dephosphorylation reaction, agents for suppressing enhancement of cell damage, and preventive and therapeutic agents for memory disorders and/or neurodegenerative disorders.

    摘要翻译: 本发明将OVARC1000473(SEQ ID NO:1)和NT2RM1000377(SEQ ID NO:3)鉴定为表达抑制福斯福林的CREB活化的克隆,并提供使用这些基因的评价方法和/或由这些基因编码的蛋白质。 此外,发现这些蛋白质增强细胞损伤。 可以根据本发明的评估方法筛选的化合物可用作抑制CREB去磷酸化反应的药剂,用于抑制细胞损伤增强的药剂,以及用于记忆障碍和/或神经变性疾病的预防和治疗剂。

    Remedy for cerebral neurodegenerative diseases using ppar agonist
    3.
    发明申请
    Remedy for cerebral neurodegenerative diseases using ppar agonist 审中-公开
    使用ppar激动剂治疗脑神经变性疾病

    公开(公告)号:US20070037882A1

    公开(公告)日:2007-02-15

    申请号:US10554109

    申请日:2004-04-15

    IPC分类号: A61K31/22

    CPC分类号: A61K31/426 A61K31/192

    摘要: In accordance with the invention, a compound with a protective action for nerve cell can be reselected by adding PPARδ agonist to a culture cell system where toxic substances such as thapsigargin, MPP+ and staurosporine are preliminarily allowed to react and reselecting a compound improving the survival rate. The compound selected by such method can be used as an active ingredient of a therapeutic agent for neurodegenerative diseases such as cerebral infarction and Parkinson's disease. Thus, the invention is very useful for research works for creating novel pharmaceutical agent.

    摘要翻译: 根据本发明,通过将PPARδ激动剂加入培养细胞系统中,可以重新选择具有保护神经细胞作用的化合物,其中预先允许有毒物质如毒胡萝卜素,MPP +和/或星孢菌素反应 并重新选择提高存活率的化合物。 通过这种方法选择的化合物可以用作神经变性疾病如脑梗死和帕金森病的治疗剂的活性成分。 因此,本发明对于创造新型药剂的研究工作非常有用。

    Semiconductor device, and thin film capacitor
    8.
    发明授权
    Semiconductor device, and thin film capacitor 有权
    半导体器件和薄膜电容器

    公开(公告)号:US06524905B2

    公开(公告)日:2003-02-25

    申请号:US09903316

    申请日:2001-07-11

    IPC分类号: H01L218242

    摘要: A semiconductor device provided with a thin film capacitor having a small equivalent series inductance is provided, which can be operated at a high frequency range and contributes to size reduction of the electronic devices. The semiconductor device comprises a device formed on a silicon substrate 1a, interlayer insulating films 3a, 3b, and 3c, wiring blocks including a power source wire block and a ground wire block, and a thin film capacitor 14 formed on an uppermost insulating layer. The thin film capacitor 14 comprises a lower electrode 6 connected to the ground wire block 4e through a contact 5d, an upper electrode 8 which is connected to the power source wire block 4d through a contact 5d, and which extends above the lower electrode 6, and a dielectric layer 7 which is inserted between the lower and the upper electrodes.

    摘要翻译: 提供了具有小等效串联电感的薄膜电容器的半导体器件,其可以在高频范围下操作并且有助于电子器件的尺寸减小。 半导体器件包括形成在硅衬底1a,层间绝缘膜3a,3b和3c上的器件,包括电源线块和接地线块的布线块,以及形成在最上层绝缘层上的薄膜电容器14。 薄膜电容器14包括通过接触件5d连接到接地线块4e的下电极6,通过接触件5d连接到电源线块4d并且在下电极6上方延伸的上电极8, 以及插入在下电极和上电极之间的电介质层7。